In Vitro Activity of Cefiderocol against U.S. and European Gram-Negative Clinical Isolates Collected in 2020 as Part of the SENTRY Antimicrobial Surveillance Program

In Vitro Activity of Cefiderocol against U.S. and European Gram-Negative Clinical Isolates Collected in 2020 as Part of the SENTRY Antimicrobial Surveillance Program

ABSTRACT Cefiderocol is a siderophore-conjugated cephalosporin with broad activity against Gram-negative (GN) bacteria, including carbapenem-resistant Enterobacterales (CRE), Pseudomonas aeruginosa, Acinetobacter spp., and Stenotrophomonas maltophilia. Cefiderocol was approved by the FDA for treatme...

Full description

Bibliographic Details
Main Authors: Dee Shortridge, Jennifer M. Streit, Rodrigo Mendes, Mariana Castanheira
Format: Article
Language:English
Published: American Society for Microbiology 2022-04-01
Series:Microbiology Spectrum
Subjects:
cefiderocol
activity
surveillance
Gram-negative bacteria
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02712-21

Internet

https://journals.asm.org/doi/10.1128/spectrum.02712-21

Similar Items